Juvenescence announces appointment of Colin Watts as CEO of Juvenescence Life

Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients

Dicerna Announces Dosing Completion in Nedosiran PHYOX™4 Clinical Trial for Treatment of Primary Hyperoxaluria Type 3

Can-Fite Receives Notice of Patent Allowance in China for NASH Treatment

Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel...

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine